Why RAG-Stiftung's 43.8% Stake Will Decide the BASF-Evonik Outcome
Why RAG-Stiftung's 43.8% Stake Will Decide the BASF-Evonik Outcome
BASF’s exploratory approach toward Evonik has turned Germany’s two largest chemical groups into the centre of an ownership drama that hinges on a single shareholder. The RAG-Stiftung holds approximately 43.8% of Evonik’s shares. Without its consent, a full takeover or control change is effectively impossible. Evonik’s management has already rejected an unsolicited proposal that valued the equity at roughly €10.3 billion, or about €22.15 per share—a premium of just over 28% to the pre-rumour price—and denied BASF access to due diligence. The foundation has confirmed that BASF contacted it regarding a possible voluntary public offer, but it has not yet taken a public position. That silence, and the foundation’s unique mandate, now set the terms of what happens next.
The Opening Salvo and Evonik’s Rejection
In late September 2026 BASF confirmed exploratory talks with both Evonik and the RAG-Stiftung over a potential acquisition. Reports put the initial equity valuation near €10.3 billion, implying an enterprise value around €14 billion including debt. Evonik’s board judged the figure too low to open formal negotiations or grant a data-room review. Shares jumped on the speculation, but the formal rejection shifted attention from management’s stance to the anchor shareholder that can force or block any subsequent move.
Why 43.8% Is Decisive
German takeover rules and practical control dynamics make a large minority block this size decisive. A bidder that acquires the foundation’s package would almost certainly trigger a mandatory offer to remaining shareholders. Conversely, a hostile or partial bid that leaves the foundation opposed faces near-certain failure. No serious combination of Germany’s two largest chemical companies can proceed against the wishes of a holder of nearly 44% of the equity. The foundation therefore functions as kingmaker: its willingness to sell, the price it demands, and any conditions it attaches will determine whether BASF can advance or must walk away.
The Foundation’s Mandate and Financial Pressures
The RAG-Stiftung exists primarily to fund the perpetual obligations of German hard-coal mining—the so-called eternity costs of pumping mine water and securing shafts after the end of commercial coal production. In 2025 it paid roughly €309 million toward those obligations. The Evonik dividend has been a major source of that cash, contributing about €252 million in the same year. The foundation has already signalled an intention to reduce its Evonik stake over time toward 25.1%, both to diversify concentrated risk and to realise capital for its long-term liabilities, whose present value is measured in tens of billions of euros. A well-priced cash exit would accelerate that diversification and strengthen the foundation’s ability to meet its statutory duties.
Acrylic Acid (99.5%) - China
Competing Interests Inside the Foundation
The foundation’s board and supervisory structures include political and labour representatives. That composition introduces additional layers: employment commitments, regional industrial policy in North Rhine-Westphalia, and the long-term security of the eternity-cost funding. A pure financial maximisation of the Evonik stake may therefore be tempered by concerns about job security at Evonik sites, the competitive structure of the German chemical industry, and the reliability of future income streams if the stake is sold. Insiders have described the foundation’s internal process as one that must reconcile multiple obligations rather than a simple auction.
Possible Paths Forward
Three broad outcomes remain open. First, the foundation could support a revised, higher BASF offer and enable a negotiated transaction, possibly with employment or site-protection commitments. Second, it could refuse to sell at prices BASF is willing to pay, leaving Evonik independent and forcing BASF to abandon or sharply alter its approach. Third, it could explore alternative buyers or a staged reduction of its stake outside a full takeover, preserving optionality while raising cash. Because the foundation has not locked itself into any of these paths, the process remains fluid and political as well as commercial.
Implications for the German Chemical Sector
A successful BASF–Evonik combination would create a significantly larger specialty and diversified chemicals platform at a moment when European producers face high energy costs, overcapacity in some chains, and intensifying global competition. Antitrust review would be extensive. A failed approach would leave both companies to pursue standalone strategies—Evonik with its ongoing efficiency programme that includes thousands of job reductions, BASF with its selective specialty growth and portfolio discipline. In either case, the RAG-Stiftung’s decision will shape the ownership map of German chemicals for years.
Outlook
RAG-Stiftung’s 43.8% stake is the single most important variable in the BASF–Evonik situation. Evonik’s management has drawn a line under the first price; the foundation now holds the leverage to demand a higher valuation, impose non-price conditions, or decline to sell. Until the foundation clarifies its stance—whether through a formal response to a revised offer or an explicit decision to remain invested—the outcome cannot be predicted from industrial logic alone. For investors, employees and competitors, the next decisive signal will come from Essen, not Ludwigshafen or the Evonik boardroom.
Sources
Found this useful?
